• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Launch One Acquisition Corp.

    11/14/24 5:40:31 PM ET
    $LPAA
    Get the next $LPAA alert in real time by email
    SC 13G 1 form_sc13g-launch.htm


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     _________________________________________

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. )*
     
     _________________________________________

    Launch One Acquisition Corp.
    (Name of Issuer)
    Class A Ordinary Shares, par value $0.0001 per share
    (Title of Class of Securities)
    G5S86M100
    (CUSIP Number)
    September 30, 2024
    (Date of event which requires filing of this statement)
     
      _________________________________________

    Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
    ☒ Rule 13d-1(b) 
    ☐ Rule 13d-1(c) 
    ☐ Rule 13d-1(d) 
     

    *
    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

             
    CUSIP No. G5S86M100
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners LLP
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United Kingdom
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    1,980,000
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    1,980,000
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,980,000
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    8.6%
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    PN, IA


             
    CUSIP No. G5S86M100
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners Limited
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Hong Kong
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    1,980,000
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    1,980,000
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,980,000
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    8.6%
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    CO, IA


             
    CUSIP No. G5S86M100
     
    13G
     
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners LLC
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    State of Delaware
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    1,980,000
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    1,980,000
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,980,000
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    8.6%
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    OO, IA


             
    CUSIP No. G5S86M100
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners AG
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Switzerland
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    1,980,000
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    1,980,000
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,980,000
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    8.6%
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    CO, IA


             
    CUSIP No. G5S86M100
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners (DIFC) Limited
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United Arab Emirates
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    1,980,000
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    1,980,000
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,980,00
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    8.6%
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    CO, IA


             
    CUSIP No. G5S86M100
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners (Ireland) Limited
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Ireland
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    1,980,000
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    1,980,000
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,980,00
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    8.6%
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    CO, IA

             
    CUSIP No. G5S86M100
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    Ben Levine
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United Kingdom
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    1,980,000
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    1,980,000
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,980,000
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    8.6%
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    IN, HC


             
    CUSIP No. G5S86M100
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    Stefan Renold
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Switzerland
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    1,980,000
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    1,980,000
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,980,000
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    8.6%
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    IN, HC


    Item 1(a).
    NAME OF ISSUER:

    The name of the issuer is Launch One Acquisition Corp. (the “Issuer”).
     
    Item 1(b).
    ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

    The Issuer’s principal executive offices are located at 180 Grand Avenue, Suite 1530, Oakland, CA 94612.
     
    Item 2(a).
    NAME OF PERSON FILING:

    This statement is filed by:
     
     
    (i)
    LMR Partners LLP, LMR Partners Limited, LMR Partners LLC, LMR Partners AG, LMR Partners (DIFC) Limited and LMR Partners (Ireland) Limited (collectively, the “LMR Investment Managers”), which serve as the investment managers to certain funds with respect to the Class A Ordinary Shares (as defined in Item 2(d)) held by certain funds; and
     
     
    (ii)
    Ben Levine and Stefan Renold, who are ultimately in control of the investment and voting decisions of the LMR Investment Managers with respect to the securities held by certain funds.

    The foregoing persons are hereinafter sometimes collectively referred to as the “Reporting Persons.”
     
    Item 2(b).
    ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

    The address of the principal business office of each of the Reporting Persons is c/o LMR Partners LLP, 9th Floor, Devonshire House, 1 Mayfair Place, London, W1J 8AJ, United Kingdom.
     
    Item 2(c).
    CITIZENSHIP:

    LMR Partners LLP is a United Kingdom limited liability partnership. LMR Partners Limited is a Hong Kong corporation. LMR Partners LLC is a Delaware limited liability company. LMR Partners AG is a Swiss corporation. LMR Partners (DIFC) Limited is a United Arab Emirates corporation. LMR Partners (Ireland) Limited is a limited company incorporated in Ireland. Ben Levine is a citizen of the United Kingdom. Stefan Renold is a citizen of Switzerland.

    Item 2(d).
    TITLE OF CLASS OF SECURITIES:

    Class A Ordinary Shares, par value $0.0001 per share (“Class A Ordinary Shares”).
     
    Item 2(e).
    CUSIP NUMBER:

    G5S86M100
     


    Item 3.
    IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:
     
             
    (a)
     
    ☐
     
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c).
         
    (b)
     
    ☐
     
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
         
    (c)
     
    ☐
     
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
         
    (d)
     
    ☐
     
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
         
    (e)
     
    ☒
     
    An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
         
    (f)
     
    ☐
     
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
         
    (g)
     
    ☒
     
    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
         
    (h)
     
    ☐
     
    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
         
    (i)
     
    ☐
     
    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
         
    (j)
     
    ☒
     
    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).
         
    (k)
     
    ☐
     
    Group, in accordance with §240.13d-1(b)(1)(ii)(K).
    If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: investment adviser.

    Item 4.
    OWNERSHIP.

    The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

    As of September 30, 2024:

    The Class A Ordinary Shares beneficially owned by the Reporting Persons are directly held by LMR Multi-Strategy Master Fund Limited (“LMR Master Fund”) and LMR CCSA Master Fund Ltd (“LMR CCSA Master Fund”). Each of LMR Master Fund and LMR CCSA Master Fund acquired 990,000 units of the Issuer’s securities (“Units”) in the Issuer’s initial public offering, with each Unit consisting of one Class A Ordinary Share and 1/2 of a warrant to purchase one Class A Ordinary Share. By virtue of holding the Units, each of LMR Master Fund and LMR CCSA Master Fund directly holds 990,000 Class A Ordinary Shares (the “LMR Shares”). The Class A Ordinary Shares held by each of LMR Master Fund and LMR CCSA Master Fund represent approximately 4.3% and LMR Shares in the aggregate represent approximately 8.6% of the outstanding Class A Ordinary Shares, based on 23,000,000 Class A Ordinary Shares of the Issuer outstanding as of August 20, 2024, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on August 20, 2024.

    In addition to the LMR Shares, by virtue of holding the Units, each of LMR Master Fund and LMR CCSA Master Fund also directly holds warrants to purchase 495,000 Class A Ordinary Shares (“Warrants”). The Warrants have an exercise price of $11.50 per Class A Ordinary Share and are exercisable 30 days after the completion of the Issuer’s initial business combination, and will expire five years after the completion of the Issuer’s initial business combination or earlier upon redemption or the Issuer’s liquidation.
     
    Item 5.
    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

    Not applicable.
     
    Item 6.
    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

    The securities beneficially owned by the Reporting Persons are directly held by LMR Master Fund and LMR CCSA Master Fund, for which the LMR Investment Managers serve as the investment managers.
     



    Item 7.
    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

    Not applicable.
     
    Item 8.
    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

    Not applicable.
     
    Item 9.
    NOTICE OF DISSOLUTION OF GROUP.

    Not applicable.

    Item 10.
    CERTIFICATION.

    Each of the LMR Investment Managers and Messrs. Levine and Renold hereby certifies as follows:

    By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    Each of the LMR Investment Managers other than LMR Partners LLC hereby certifies as follows:

    By signing below, I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to an investment adviser is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Securities and Exchange Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.



    SIGNATURES

    After reasonable inquiry and to the best of our knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATED: November 14, 2024
     
         
    LMR PARTNERS LLP
       
    By:
     
    /s/ Shane Cullinane
    Name:
     
    Shane Cullinane
    Title:
     
    Chief Operating Officer
     
    LMR PARTNERS LIMITED
       
    By:
     
    /s/ Shane Cullinane
    Name:
     
    Shane Cullinane
    Title:
     
    Chief Operating Officer

    LMR PARTNERS LLC
       
    By:
     
    /s/ Allyson Hanlon
    Name:
     
    Allyson Hanlon
    Title:
     
    US Legal Counsel
     
    LMR PARTNERS AG
       
    By:
     
    /s/ Shane Cullinane
    Name:
     
    Shane Cullinane
    Title:
     
    Chief Operating Officer

    LMR PARTNERS (DIFC) LIMITED
       
    By:
     
    /s/ Shane Cullinane
    Name:
     
    Shane Cullinane
    Title:
     
    Chief Operating Officer

    LMR PARTNERS (IRELAND) LIMITED
       
    By:
     
    /s/ Shane Cullinane
    Name:
     
    Shane Cullinane
    Title:
     
    Chief Operating Officer
         
    /s/ Ben Levine
       
    BEN LEVINE
       

    /s/ Stefan Renold
    STEFAN RENOLD


    EXHIBIT 99.1
    JOINT FILING AGREEMENT
    PURSUANT TO RULE 13d-1(k)
    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
    DATED: November 14, 2024
     
         
    LMR PARTNERS LLP
       
    By:
     
    /s/ Shane Cullinane
    Name:
     
    Shane Cullinane
    Title:
     
    Chief Operating Officer
     
    LMR PARTNERS LIMITED
       
    By:
     
    /s/ Shane Cullinane
    Name:
     
    Shane Cullinane
    Title:
     
    Chief Operating Officer

    LMR PARTNERS LLC
       
    By:
     
    /s/ Allyson Hanlon
    Name:
     
    Allyson Hanlon
    Title:
     
    US Legal Counsel
     
    LMR PARTNERS AG
       
    By:
     
    /s/ Shane Cullinane
    Name:
     
    Shane Cullinane
    Title:
     
    Chief Operating Officer

    LMR PARTNERS (DIFC) LIMITED
       
    By:
     
    /s/ Shane Cullinane
    Name:
     
    Shane Cullinane
    Title:
     
    Chief Operating Officer

    LMR PARTNERS (IRELAND) LIMITED
       
    By:
     
    /s/ Shane Cullinane
    Name:
     
    Shane Cullinane
    Title:
     
    Chief Operating Officer
         
    /s/ Ben Levine
       
    BEN LEVINE
       

    /s/ Stefan Renold
    STEFAN RENOLD



    Get the next $LPAA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LPAA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LPAA
    SEC Filings

    View All

    SEC Form 10-K filed by Launch One Acquisition Corp.

    10-K - Launch One Acquisition Corp. (0002015502) (Filer)

    3/27/26 4:20:16 PM ET
    $LPAA

    SEC Form 425 filed by Launch One Acquisition Corp.

    425 - Launch One Acquisition Corp. (0002015502) (Subject)

    3/26/26 4:06:19 PM ET
    $LPAA

    Launch One Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - Launch One Acquisition Corp. (0002015502) (Filer)

    3/26/26 4:05:08 PM ET
    $LPAA

    $LPAA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

    HAIFA, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. ("Minovia" or the "Company"), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, today announced that it has been granted two new U.S. patents that further expand and strengthen its global intellectual property portfolio supporting its proprietary Mitochondrial Augmentation Therapy (MAT) platform. The newly granted patents cover mitochondrial augmentation therapy for primary mitochondrial diseases and mitochondrial augmentation therapy for renal diseases, providing extended protection for Minovia's core platform technology. Corresponding

    1/13/26 9:51:59 AM ET
    $LPAA

    Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition

    HAIFA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. ("Minovia" or the "Company"), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that data collected by research teams at Memorial Sloan Kettering Cancer Center (MSK) and Shaare Zedek Medical Center (SZMC) featuring the Company's mitochondrial augmentation technology in myelodysplastic syndrome (MDS) will be presented at the 67th American Society of Hematology's (ASH) Annual Meeting and Exposition on December 6-9, 2025 in Orlando, FL. The data will be featured in an oral presentation to be held on Saturday, Dec 6, 2PM ET (abs25-

    11/20/25 8:30:00 AM ET
    $LPAA

    Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome

    HAIFA, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. ("Minovia" or the "Company"), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to the Company's lead investigational compound, MNV-201 for Myelodysplastic Syndrome (MDS), a serious age-related hematopoietic disease. This designation is in addition to the existing FDA Fast Track Designation in MDS, as well as both Fast Track and Rare Pediatric Disease Designations for MNV-201 in the treatment of Pearson Syndrome. "We continue to receive

    10/15/25 7:30:00 AM ET
    $LPAA

    $LPAA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Launch One Acquisition Corp.

    SC 13G - Launch One Acquisition Corp. (0002015502) (Subject)

    11/14/24 9:03:16 PM ET
    $LPAA

    SEC Form SC 13G filed by Launch One Acquisition Corp.

    SC 13G - Launch One Acquisition Corp. (0002015502) (Subject)

    11/14/24 5:40:31 PM ET
    $LPAA

    SEC Form SC 13G filed by Launch One Acquisition Corp.

    SC 13G - Launch One Acquisition Corp. (0002015502) (Subject)

    11/14/24 1:34:17 PM ET
    $LPAA